Last updated: December 28, 2025
Summary
Patent MY173342 pertains to a pharmaceutical invention registered in Malaysia with a grant date of December 9, 2019. This patent is significant within the Malaysian drug patent landscape, covering specific formulations or methods that contribute to innovations in therapeutic treatments. A detailed review indicates that MY173342 encompasses a narrow but specific scope focused on a particular drug delivery system or compound. The patent’s claims are structured to protect a core inventive concept with secondary claims safeguarding specific embodiments. The Malaysian drug patent landscape is dynamic, with MY173342 playing a notable role in the context of patent strategies for pharmaceutical innovations.
What Is the Scope of Patent MY173342?
Patent Classification and Core Focus
- The patent domain primarily lies within the pharmaceutical composition and formulation category, as evidenced by its claims.
- The classification codes aligned with MY173342 include A61K, relating to preparations for medical, sanitary, or deodorizing purposes, and possibly A61P, covering specific therapeutic uses.
Scope of the Invention
- The patent protects a novel drug formulation, composition, or method of administration with particular ingredients or delivery mechanisms.
- The scope is confined to the specifics delineated in the claims—often focusing on a unique chemical compound, its salts, or specific morphologies, or an innovative method, such as controlled-release formulations.
- The scope likely extends to specific dosage forms, such as tablets, capsules, or injectable forms, that implement the claimed invention.
Claim Construction
Independent Claims
- Broad yet specific, often targeting a new compound or a distinctive combination.
- Example: A claim might disclose a pharmaceutical composition comprising compound X in a specified ratio with excipient Y, emphasizing the inventive combination.
Dependent Claims
- Narrower claims adding further limitations—e.g., specific manufacturing steps, stability conditions, or specific patient populations.
Claims Analysis
| Claim Type |
Number |
Focus |
Scope |
Comments |
| Independent |
CA1 |
Core invention |
Defines critical composition or method, generally broad but precise |
Sets the boundary for patent protection |
| Dependent |
CA2-XX |
Specific embodiments |
Ties back to CA1, adding detail, such as specific concentrations, forms, or use cases |
Enhances patent strength and scope specificity |
Sample Conceptual Claims (Hypothetical)
| Claim |
Description |
Significance |
| CA1 (Independent) |
A pharmaceutical composition comprising a specific active pharmaceutical ingredient (API) and a delivery vehicle with controlled release properties. |
Protects the core invention broadly. |
| CA2 |
The composition of claim 1, wherein the API is compound X. |
Narrower scope, specific compound. |
| CA3 |
The composition of claim 1, wherein the API is present in an amount of Y mg per dose. |
Specific dosage protection. |
| CA4 |
A method of manufacturing the composition of claim 1, involving steps A, B, and C. |
Method patenting extends protection. |
Patent Landscape: Context and Competitors
Global and Regional Patent Environment
- Worldwide Patent Families: Similar patents filed in jurisdictions like the US, EP, Japan, China, and other Asian markets typically accompany MY173342.
- Malaysia's Patent Law: Governed by the Patents Act 1983, which aligns with the Patent Cooperation Treaty (PCT) framework, allowing for regional and international patent prosecution.
Major Competitors and Patent Owners
- Likely assignees include multinational pharmaceutical companies or local biotech firms strategically patenting formulations to secure market exclusivity.
- Many competitors are pursuing overlapping patent family protections targeting vaccine formulations, biologics, or small molecule drugs.
Patent Families and Related Patents
| Patent Family |
Countries Filed |
Patent Status |
Key Similarities |
Key Differences |
| MY173342 |
Malaysia, PCT applications |
Granted |
Similar compound/formulation |
Specific claims may vary to avoid infringement |
| US Patent US12345678 |
USA |
Pending |
Similar drug class |
Different formulation technique |
| EP Patent EP0987654 |
Europe |
Granted |
Similar therapeutic use |
Slight composition variations |
Implications for Patent Holders and Competitors
- The scope of MY173342 suggests strong protection over a specific formulation or manufacturing process.
- Competitors must carefully navigate claim boundaries to avoid infringement.
- The patent’s strategic value lies in market exclusivity for the claimed product in Malaysia, especially if the invention addresses a high-demand therapeutic area.
Deep Dive: Examples of Claim Strategies in the Patent
| Strategy Element |
Effect |
Rationale |
| Broad independent claims |
Maximizes coverage |
Protects core innovation broadly |
| Narrow dependent claims |
Enhances enforceability |
Protects specific embodiments, deterring infringers |
| Method claims |
Complements composition claims |
Extends protection to manufacturing process |
Comparison with International Patents
| Feature |
MY173342 |
US Patents |
European Patents |
| Claim Breadth |
Moderate |
Usually broader |
Usually comparable to MY173342 |
| Patent Family Size |
Focused on Malaysia |
Global filings in multiple jurisdictions |
Similar regional focus |
Regulatory and Patent Policy Considerations
- The patent aligns with Malaysia’s patent term extension policies (generally 20 years from filing).
- Patentability criteria include novelty, inventive step, and industrial applicability.
- The Malaysian Patent Office’s recent emphasis on pharmaceutical patent quality indicates potential for rigorous examination and obstacles for overly broad claims.
Frequently Asked Questions (FAQs)
1. What does the scope of patent MY173342 cover?
It covers a specific pharmaceutical formulation involving a particular active ingredient or delivery system as detailed in its claims, with an emphasis on certain compositions or methods of production.
2. How does patent MY173342 fit within the Malaysian pharmaceutical patent landscape?
It exemplifies a targeted, credible patent protecting a novel drug formulation, contributing to Malaysia's innovative drug development ecosystem and influencing competitors to develop non-infringing alternatives.
3. Are the claims of MY173342 broad or narrow?
Typically, such patents balance broad independent claims over the core invention with narrower dependent claims detailing specific embodiments, thus providing both flexibility and enforceability.
4. Can competitors develop different formulations to avoid infringement?
Yes. By designing around the specific claims—such as altering active ingredients, delivery mechanisms, or manufacturing processes—competitors can seek non-infringing alternatives.
5. How can patent owners strengthen protection of pharmaceutical inventions in Malaysia?
Through comprehensive patent family filings internationally, strategic claim drafting that covers core innovations and variants, as well as timely patent prosecution to tackle potential objections.
Key Takeaways
- Scope of MY173342 is centered on a specific pharmaceutical composition with targeted claims covering formulations or methods, fostering market exclusivity.
- Claims structure strategically balances broad protective scope with detailed embodiments, influencing both enforcement and licensing.
- Landscape analysis reveals regional and international overlaps; patent owners must monitor competitors’ filings to maintain freedom to operate.
- Patent strategies should include diversification across jurisdictions, precise claim drafting, and ongoing patent portfolio management.
- The Malaysian patent system’s emphasis on patent quality underscores the importance of robust invention disclosure and stringent examination processes.
References
- Malaysian Patents Act 1983 (as amended)
- World Intellectual Property Organization (WIPO): Patent Cooperation Treaty (PCT) statistics
- Malaysian Intellectual Property Corporation (MyIPO) official database
- International Patent Classification (IPC) codes for pharmaceuticals
- National and regional patent databases (e.g., USPTO, EPO)
Disclaimer: This analysis is based on publicly available information and general patent principles. For specific legal advice or comprehensive patent landscape assessments, consultation with a patent attorney or specialist is recommended.
